Advertisements


Iovance Biotherapeutics reports results from FDA end of Phase 2 meeting

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 11th, 2018

Cerus reports results of SPARC Phase 3 study at EHA meeting

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 15th, 2018

Loxo Oncology Reports First Quarter 2018 Financial Results

- LOXO-292 Phase 1 Oral Presentation Upcoming at 2018 ASCO Annual Meeting - - LOXO-292 Preclinical and Cl.....»»

Category: earningsSource: benzingaMay 8th, 2018

Gold Standard Ventures reports Phase 2 results from Dixie Deposit

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 12th, 2019

CytRx reports positive Phase 2/3 results for arimoclomol in NPC

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 6th, 2019

MacroGenics reports "positive" results from Phase 3 SOPHIA study of margetuximab

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 6th, 2019

Scynexis reports "positive" interim Phase 2 results for ibrexafungerp

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 30th, 2019

Altimmune reports presentation of HepTcell Phase 1 results at EASL

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 29th, 2019

Alexion reports "positive" results from Phase 3 study of ULTOMIRIS

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 28th, 2019

Atossa Genetics reports final results from Phase 1 Endoxifen study in males

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 9th, 2019

Spero Therapeutics reports "positive" feedback from FDA pre-Phase 3 meeting

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 7th, 2019

Puma Biotechnology reports top-line results from Phase III NALA trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 17th, 2018

AMREP Reports Second Quarter Fiscal 2019 Results

PLYMOUTH MEETING, Pa., Dec. 11, 2018 (GLOBE NEWSWIRE) -- AMREP Corporation (NYSE:AXR) today reported net income of $55,000, or $0.00 per share, for its 2019 second fiscal q.....»»

Category: earningsSource: benzingaDec 11th, 2018

Alkermes reports positive results in trial of schizophrenia treatment that reduces weight gain

Alkermes Plc announced positive results Thursday for a trial of its ALKS 3832 treatment for schizophrenia. The Phase 3 tr.....»»

Category: topSource: marketwatchNov 29th, 2018

InflaRx N.V. Reports Third Quarter 2018 Financial & Operating Results

Completion of patient recruitment in phase IIb trial in Hidradenitis Suppurativa First pa.....»»

Category: earningsSource: benzingaNov 21st, 2018

Qudian Inc. Reports Third Quarter 2018 Unaudited Financial Results and Issues Notice of Annual General Meeting

Qudian Inc. Reports Third Quarter 2018 Unaudited Financial Results and Issues Notice of Annual General Meeting.....»»

Category: earningsSource: benzingaNov 21st, 2018

Denali Therapeutics reports "positive" results from Phase 1 DNL747 study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 19th, 2018

Atara Biotherapeutics announces publication of Phase 1 ATA190 results

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 19th, 2018

Leju Reports Third Quarter 2018 Results and Issues Notice of Annual General Meeting

Leju Reports Third Quarter 2018 Results and Issues Notice of Annual General Meeting.....»»

Category: dealsSource: nytNov 19th, 2018

Diffusion Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Business Update

Highlights Include FDA Approval of Phase 2 On-Ambulance Clinical Trial for Treatment of Stroke and Appointment of New Chief Financial Off.....»»

Category: earningsSource: benzingaNov 14th, 2018

Nightstar Announces Planned Initiation of Phase 2/3 Expansion Study in XIRIUS Trial for NSR-RPGR in XLRP and Reports Third Quarter 2018 Financial Results

Phase 2/.....»»

Category: earningsSource: benzingaNov 13th, 2018